Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologics for the primary care physician: Review and treatment of psoriasis
Eric D. Schadler, Bernhard Ortel, Stephanie Mehlis
Disease-a-Month (2018) Vol. 65, Iss. 3, pp. 51-90
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 216
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Rohan Singh, Sindhuja Koppu, Patrick O. Perche, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12793-12793
Open Access | Times Cited: 110
Effect of Very-Low-Calorie Ketogenic Diet on Psoriasis Patients: A Nuclear Magnetic Resonance-Based Metabolomic Study
Giuseppe Castaldo, Imma Pagano, Manuela Grimaldi, et al.
Journal of Proteome Research (2020) Vol. 20, Iss. 3, pp. 1509-1521
Open Access | Times Cited: 80
Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Harman Bakshi, Manju Nagpal, Manjinder Singh, et al.
Current Drug Safety (2020) Vol. 15, Iss. 2, pp. 82-104
Closed Access | Times Cited: 79
Gamma Delta T Cells and Their Pathogenic Role in Psoriasis
Cong Qi, Yazhuo Wang, Ping Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease
Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 3, pp. 444-444
Open Access | Times Cited: 44
From Diagnosis to Treatment: A Review of AI Applications in Psoriasis Management
Eyerusalem Gebremeskel, Gelane Biru, Honey Gemechu, et al.
Journal of Electrical Engineering and Technology (2025)
Closed Access | Times Cited: 1
Biomarkers of Inflammation in Obesity-Psoriatic Patients
Carmen Rodríguez‐Cerdeira, Mónica Cordeiro-Rodríguez, Miguel Carnero-Gregorio, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 62
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 228-228
Open Access | Times Cited: 29
Recent advances in microneedle designs and their applications in drug and cosmeceutical delivery
Rabinarayan Parhi
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103639-103639
Closed Access | Times Cited: 23
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
Kerasia‐Maria Plachouri, Sophia Georgiou
Journal of Dermatological Treatment (2018) Vol. 30, Iss. 7, pp. 668-673
Closed Access | Times Cited: 39
Secukinumab induced Behçet’s syndrome: a report of two cases
Elif Dincses, Berna Yurttaş, Sinem Nihal Esatoğlu, et al.
Oxford Medical Case Reports (2019) Vol. 2019, Iss. 5
Open Access | Times Cited: 36
Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways
Husna Kadagothy, Shweta Nene, Etikala Amulya, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175668-175668
Closed Access | Times Cited: 11
<p>Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review</p>
Andreas Pinter, Bernd Bonnekoh, Ina M. Hadshiew, et al.
Clinical Cosmetic and Investigational Dermatology (2019) Vol. Volume 12, pp. 509-517
Open Access | Times Cited: 30
Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation
Fereshteh Bayat, Reza Hosseinpour-Moghadam, Fatemeh Mehryab, et al.
Advances in Colloid and Interface Science (2020) Vol. 277, pp. 102121-102121
Closed Access | Times Cited: 30
Influence of phytochemicals in induced psoriasis (Review)
Elena Niculeț, Diana Sabina Radaschin, Florentina Năstase, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 28
Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies
Krishna Yadav, Deependra Singh, Manju Rawat Singh
European Journal of Pharmacology (2021) Vol. 907, pp. 174254-174254
Closed Access | Times Cited: 24
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
Karine Rodríguez-Fernández, Víctor Mangas‐Sanjuán, Matilde Merino‐Sanjuán, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 654-654
Open Access | Times Cited: 18
Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-il 17 and anti-il 23 monoclonal antibodies: a retrospective observational study
Alessandra Michelucci, Flavia Manzo Margiotta, Filippo Fanetti, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
Unveiling the revolutionary approach for psoriasis management: Leveraging the breakthrough capabilities of hyaluronic acid
Abhipsa Priyadarshinee, Etikala Amulya, Ganesh Vambhurkar, et al.
International Journal of Biological Macromolecules (2025), pp. 143089-143089
Closed Access
Challenges in the treatment of psoriasis with biologics: vaccination, history of malignancy, human immunodeficiency virus (HIV) infection, and pediatric psoriasis
Kerasia‐Maria Plachouri, Sophia Georgiou
International Journal of Dermatology (2019) Vol. 58, Iss. 9, pp. 1008-1013
Closed Access | Times Cited: 26
Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis
Qian Yu, Yunlei Tong, Lian Cui, et al.
International Immunopharmacology (2019) Vol. 73, pp. 442-450
Closed Access | Times Cited: 26
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection
Manuela Ceccarelli, Emmanuele Venanzi Rullo, Massimiliano Berretta, et al.
Dermatologic Therapy (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 25
<p>Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date</p>
Marco Galluzzo, S. D’Adamio, Antonio Massaro, et al.
Clinical Cosmetic and Investigational Dermatology (2019) Vol. Volume 12, pp. 311-321
Open Access | Times Cited: 24
Photodynamic Therapy of Psoriasis Using Photosensitizers of Vegetable Origin
Marcos Luciano Bruschi, Jéssica Bassi da Silva, Hélen Cássia Rosseto
Current Pharmaceutical Design (2019) Vol. 25, Iss. 20, pp. 2279-2291
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top